Marex director granted 2,070 restricted shares

Marex Group plc director Assi Georges reported an equity award.

Rhea-AI Filing Summary

Marex Group plc director Assi Georges reported an equity award. On June 9, 2026, he was granted 2,070 Ordinary Shares at a price of $0.00 per share as a restricted share award. The filing notes these awards are contingent rights that convert into one Ordinary Share each upon vesting and settlement, giving him 2,070 shares reported as directly owned after the grant.

Insights

Equity compensation analyst

Director received a small equity grant as compensation, not an open‑market share purchase.

The filing shows director Assi Georges received 2,070 Marex Group plc Ordinary Shares on June 9, 2026 via a grant coded "A". The price per share is $0.00, confirming this is a compensation-related restricted share award, not a market transaction.

A footnote explains these 2,070 shares are restricted share awards, each a contingent right to one share upon vesting and settlement. Following the grant, his reported direct holding is 2,070 shares, indicating a relatively small, routine award with limited standalone impact on shareholders.

Insider Trade Summary

Grant/Award: 2,070 shares

Grant/Award 1 txn

Insider Assi Georges

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,070	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 2,070 shares (Direct)

Footnotes (1)

1. F1. The number of ordinary shares reported herein consists of 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Key Figures

Restricted shares granted: 2,070 shares Grant price per share: $0.00 per share Shares held after transaction: 2,070 shares

3 metrics

Restricted shares granted 2,070 shares Ordinary Shares award on June 9, 2026

Grant price per share $0.00 per share Equity award to director Assi Georges

Shares held after transaction 2,070 shares Direct ownership following the grant

Key Terms

restricted share awards, contingent right, vesting and settlement, Ordinary Shares

4 terms

restricted share awards financial

"consists of 2,070 shares underlying restricted share awards granted to the Reporting Person"

Restricted share awards are grants of company stock given to employees or executives that cannot be sold or transferred until certain conditions—typically staying with the company for a set time or meeting performance goals—are met. They matter to investors because they can dilute existing shares when they vest, signal management’s incentives and confidence, and affect a company’s future earnings per share much like a delayed paycheck that becomes available only after you meet agreed milestones.

contingent right financial

"Each award represents a contingent right to receive one (1) ordinary share"

vesting and settlement financial

"upon vesting and settlement of the applicable award"

Ordinary Shares financial

"The number of ordinary shares reported herein consists of 2,070 shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Marex Group plc (MRX) director Assi Georges report in this Form 4?

Director Assi Georges reported receiving 2,070 Marex Group plc Ordinary Shares through an equity award. These were granted at a price of $0.00 per share as restricted share awards, representing compensation rather than an open-market stock purchase or sale.

Was the Marex Group plc (MRX) Form 4 transaction a stock purchase or a grant?

The transaction was a grant, not a purchase. Code "A" and a $0.00 per-share price show 2,070 Ordinary Shares were awarded to Assi Georges as restricted share awards, reflecting equity compensation instead of an open-market acquisition of Marex Group plc shares.

How many Marex Group plc (MRX) shares did Assi Georges hold after this award?

After the reported transaction, Assi Georges is shown holding 2,070 Marex Group plc Ordinary Shares directly. This entire amount comes from the restricted share awards granted on June 9, 2026, as disclosed in the Form 4 filing’s ownership figures.

What are the terms of the Marex Group plc (MRX) restricted share awards granted to Assi Georges?

The restricted share awards give Assi Georges a contingent right to 2,070 Ordinary Shares of Marex Group plc. Each award converts into one share upon vesting and settlement, meaning he receives the actual shares only when the vesting conditions are satisfied.

Does the Marex Group plc (MRX) Form 4 indicate any stock sales by Assi Georges?

The Form 4 does not report any stock sales by Assi Georges. It shows only an acquisition coded as a grant of 2,070 restricted share awards at $0.00 per share, which increases his reported direct holdings in Marex Group plc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Assi Georges

(Last) (First) (Middle)

C/O MAREX GROUP PLC, 155 BISHOPSGATE

(Street)

LONDON UNITED KINGDOM EC2M 3TQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marex Group plc [ MRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/09/2026		A		2,070	A	$0	2,070(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The number of ordinary shares reported herein consists of 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

	/s/ Scott Linsley as Attorney-in-Fact, for Georges Assi	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)